AmCham Bulgaria Position on 2022 NHIF Budget for Medicines

On February 3rd, 2022, AmCham Bulgaria Healthcare Committee send its official statement on the 2022 National Healthcare Insurance Fund Budget (NHIF). It was addressed to the Minister of Healthcare, to the Chair of the Healthcare Commission of the Parliament, to the Chair of the Supervisory Board of NHIF, and to the Executive Director of NHIF. On February 4th, 2022 is the first hearing at the Parliamentary Healthcare Commission of the 2022 NHIF Budget

In a nutshell the position says:

  • There should be predictability in the planning in both the NHIF and the pharmaceutical companies in order to provide access to quality treatment and to deliver medicine to the Bulgarian patients.
  • There should be fairness in methodology and budgeting that reflects real needs and spending in the HC system without harming the supplies.
  • There is a gap between the 2022 NHIF Budget estimation and the expected cost for innovative medicine at app. BGN 25 M. It could increase to BGN 300 M if the pandemic develops in 2022.
  • There is no need a new group of medicines to be introduced on vague and non-transparent criteria.

Read the full position in Bulgarian